Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Shares Outstanding (Weighted Average) (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Shares Outstanding (Weighted Average) readings, the most recent being $11.6 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 8.39% to $11.6 billion in Q1 2026 year-over-year; TTM through Feb 2026 was $11.6 billion, a 8.39% increase, with the full-year FY2025 number at $10.7 billion, up 3.86% from a year prior.
  • Shares Outstanding (Weighted Average) reached $11.6 billion in Q1 2026 per CBIH's latest filing, roughly flat from $11.6 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $11.6 billion in Q3 2025, with the low at $8.1 billion in Q4 2022.
  • A 5-year average of $10.3 billion and a median of $10.4 billion in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Year-over-year, Shares Outstanding (Weighted Average) rose 27.7% in 2023 and then grew 1.23% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $8.1 billion in 2022, then rose by 27.7% to $10.3 billion in 2023, then grew by 1.6% to $10.5 billion in 2024, then grew by 10.76% to $11.6 billion in 2025, then changed by 0.0% to $11.6 billion in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Shares Outstanding (Weighted Average) are $11.6 billion (Q1 2026), $11.6 billion (Q4 2025), and $11.6 billion (Q3 2025).